Scheme of Limb Warming Blanket Combined With Dexmedetomidine

NCT ID: NCT05857410

Last Updated: 2023-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-01

Study Completion Date

2023-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: To observe the clinical effect of lower limb warming blanket combined with dexmedetomidine (DEX) in preventing postoperative delirium (POD) and chills in elderly patients undergoing spinal surgery. Methods: A total of 160 elderly patients undergoing posterior spinal surgery under general anesthesia were selected and divided into control group (group N), heating group (group T), DEX group (group D) and heating combined with DEX group (group TD) according to the random number table method, 40 cases in each group. T group and TD group routine insulation and lower limb heating blanket. DEX was injected in group D and group TD. The dosage of anesthetics, the changes of body temperature and heart rate at different time points during operation, and the occurrence of postoperative chills and POD were compared among the groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spine Surgery Postoperative Delirium and Chills

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group (group N)

Group Type NO_INTERVENTION

No interventions assigned to this group

heating group (group T)

Group Type ACTIVE_COMPARATOR

Lower limb heating blanket

Intervention Type DEVICE

Beijing Maikang Medical Device Co., Ltd., Model: Warm-1-1.

DEX group (group D)

Group Type ACTIVE_COMPARATOR

Dexmetomidine

Intervention Type DRUG

Dexmetomidine (H20183219) 0.4μg / (kg·min);

heating combined with DEX group (group TD)

Group Type EXPERIMENTAL

Dexmetomidine

Intervention Type DRUG

Dexmetomidine (H20183219) 0.4μg / (kg·min);

Lower limb heating blanket

Intervention Type DEVICE

Beijing Maikang Medical Device Co., Ltd., Model: Warm-1-1.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexmetomidine

Dexmetomidine (H20183219) 0.4μg / (kg·min);

Intervention Type DRUG

Lower limb heating blanket

Beijing Maikang Medical Device Co., Ltd., Model: Warm-1-1.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: between 65-80 years old;
* American Society of Anesthesiologists (ASA) grade II-III;
* Normal body temperature before operation;
* the operation time was 2-4 hours

Exclusion Criteria

* Preoperative fever or hypothermia (body temperature≥37.5 ℃ or≤35.5℃ on the day of operation);
* Body mass index (BMI) \>30 kg/m2;
* The existence of heart, brain, lung, kidney and other important organs and circulatory system, respiratory system, immune system, central nervous system diseases;
* Patients who had taken antipsychotic drugs or β-blockers before surgery would have a greater impact on intraoperative body temperature and other patients who could not effectively cooperate with this study;
* Patients with operation time more than 5 hours
Minimum Eligible Age

65 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jincheng General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wei Fan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jincheng General Hospital

Jincheng, Shanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JinchengGH001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Temperature Management on Postoperative Delirium
NCT06406257 NOT_YET_RECRUITING NA